Digestive system diseases

Irritable bowel syndrome drug given green light for use in Europe

The European Commission has granted a marketing authorisation to a first-in-class treatment for irritable bowel syndrome (IBS) called eluxadoline (Truberzi) for use in the EU.…

Biosimilars and inflammatory bowel disease: a switch programme using CT-P13

How to plan and manage switching patients from a biologic to a biosimilar in inflammatory bowel disease, using the University Hospital Southampton NHS Foundation Trust’s experience as an example.…

Community pharmacy could detect unknown cases of coeliac disease

A proof of concept study has shown how opportunistic testing in community pharmacies may help identify those with coeliac disease who would not otherwise have been tested.…

How to tailor medication formulations for patients with dysphagia

An overview of dysphagia and how to ensure patients are receiving the safest and most efficacious oral formulations.…

Obeticholic acid gets US approval for rare liver disease

The US Food and Drug Administration has approved a new drug called Ocaliva (obeticholic acid) for patients with primary biliary cholangitis. …

Meet the regional finalists of I Love My Pharmacist: Southern England and the Channel Islands

The public has until 21 July 2016 to vote for their favourite regional finalist of the 2016 I Love My Pharmacist Award. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion.…

Viral suppression restores life expectancy in hepatitis C-related cirrhosis

Study shows sustained virologic response in patients with hepatitis C and cirrhosis dramatically improves survival.…

Novel drug ozanimod effective in ulcerative colitis

Study results show 16% of patients receiving ozanimod were in remission after eight weeks of treatment.…

FDA approves first treatment for stem cell transplant patients who develop rare liver condition

The US Food and Drug Administration has approved a new treatment for hepatic veno-occlusive disease, a rare and life threatening liver condition that can develop in cancer patients who undergo hematopoietic stem cell transplantation.…

Eluxadoline effective for a third of IBS patients

Patients taking 100mg dose of eluxadoline saw improvements in IBS symptoms during the first 26 weeks of treatment.…